Full-Dose Anticoagulation Cuts VTE in Severe COVID-19

(MedPage Today) -- BARCELONA -- Full-dose anticoagulation prevented thromboembolic events in critically ill COVID-19 patients in the COVID-PACT trial. However, modest antithrombotic doses and colchicine didn't pan out in or out of the hospital...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news